Matt has extensive experience leading strategic engagements supporting business development and commercialization strategy. Matt has broad experience across all major therapeutic areas with a particular focus on oncology. His clients span biotech, mid-size pharma, and large pharma, and his expertise includes new product planning strategy, portfolio prioritization, therapeutic area and corporate growth strategy, and business development / licensing support. He also works with many life sciences investors conducting due diligences on both therapeutics and life sciences services businesses.
Matt has 10+ years of experience in life-sciences-related consulting. Prior to joining ClearView, Matt worked as a Senior Consultant at IMS Consulting Group in New York and in Investor Relations for IQVIA. Prior to that, he worked provider consulting with MedAssets. He received an MBA from the Northwestern’s Kellogg School of Management and a B.S. in biomedical engineering from Vanderbilt University.
Debbi Amanti Belanger
Klaus Bredl
Seth Berman
Steven Chao
Rishi Dalsania
David Gilman
Kim Goh
Ketan Kapadia
Philip Kenner
Eva Kersey
Stuart MacGregor
David McClain
Richard Mynahan
Kevin Richard
Mike Rizzo
Mike Roy
Bill Shew
Ryan Tubman
Sam Ulin
Debbie Zhuang
Jim Caruso
Sidnee Pinho
Kristine Hyde
Jonathan Betts
Dean Griffiths
Jonathan Hodgson
Slater Hurst
Andrew Kang
Dave Konciak
Alexander Lehrman
Charles Mathews
Olivia Piccione
Kai-Ming Pu
Sarah Stapleton
Brian Quinn
Michael Agne
Jessica Berard
Beko Binder
Liang Dong
Maneesh Gujrati
Peter Goldman
Austin Hubbert
Owen Im
Jonny Juliano
Patrick Kuettner
Joanna Lee
Alec Marchuk
Matthew Murphy
Mike Murray
Soyeon Park
Matthew Pfister
Cem Salfati
Kelsey Yardumian
Lainey Miller
Melanie Robinson